Lamiae Grimaldi-Bensouda1, Michel Rossignol2, Isabelle Koné-Paut3, Alain Krivitzky4, Christine Lebrun-Frenay5, Johanna Clet6, David Brassat7, Caroline Papeix8, Marc Nicolino9, Pierre-Yves Benhamou10, Olivier Fain11, Nathalie Costedoat-Chalumeau12, Marie-France Courcoux13, Jean-François Viallard14, Bertrand Godeau15, Thomas Papo16, Patrick Vermersch17, Isabelle Bourgault-Villada18, Gerard Breart19, Lucien Abenhaim20. 1. LASER Analytica, 10 Place de Catalogne, 75014 Paris, France; Conservatoire National des Arts et Métiers, 292 Rue Saint-Martin, 75003 Paris, France. Electronic address: Lamiae.Grimaldi@la-ser.com. 2. LASER Analytica, 10 Place de Catalogne, 75014 Paris, France; Department of Epidemiology, Biostatistics and Occupational Health, McGill University, 1,020 Pine ave. West, Montréal, Québec, H3A 1A2, Canada. Electronic address: Michel.Rossignol@mcgill.ca. 3. Service de Rhumatologie Pédiatrie, Centre Hospitalier Universitaire (CHU) Kremlin Bicêtre, Assistance Publique-Hôpitaux de Paris (AP-HP), Le Kremlin-Bicêtre, 3 Avenue Victoria, 75004 Paris, France; Centre de Référence des Maladies Auto-Inflammatoires (CeRéMAI), CHU de Bicêtre, 78 rue du Général Leclerc, 94270 Le Kremlin Bicêtre, France. 4. Département de Médecine Interne et Endocrinologie, Hôpital Universitaire Avicenne, Université de Paris, 125 Rue de Stalingrad, 93000 Bobigny, France. 5. Département de Neurologie, CHU de Nice, 4 Avenue Reine Victoria, 06003 Nice, France. 6. Service de Rhumatologie Pédiatrique, Centre de compétence des Arthrites Juvéniles Idiopathiques et des Maladies auto-inflammatoires, Hôpital des enfants, Place Amélie Raba Léon, 33000 Bordeaux, France. 7. Département de Neurologie, CHU de Toulouse, Place du Docteur Baylac, TSA 40031 - 31059, Toulouse, France. 8. Département de Neurologie, AP-HP, Pitié-Salpêtrière Hospital, 47-83 Boulevard de l'Hôpital, 75013 Paris, France. 9. Endocrinologie, Diabétologie, Nutrition Pédiatriques, Hôpital Femme-Mère-Enfant, Hospices Civils de Lyon, 2 Avenue Doyen Jean Lépine, 69500 Bron, France. 10. Service d'Endocrinologie-Diabétologie - maladies de la nutrition, CHU Grenoble Alpes, Boulevard de la Chantourne, 38700 La Tronche, France. 11. Service de Médecine Interne, CHU de Caen, Avenue de la Côte de Nacre, 14003 Caen, France. 12. Service de Médecine Interne, Hôpital Cochin, AH-HP, 27, rue du Faubourg-Saint-Jacques, 75014 Paris, France. 13. Service d'Hémato-Immuno-Oncologie Pédiatrie, Hôpital Armand-Trousseau, AP-HP, 26 Avenue du Dr Arnold Netter, 75012 Paris, France. 14. Service de Médecine Interne et Maladies Infectieuses, CHU de Bordeaux, 1, rue Jean Burguet, 33000 Bordeaux, France. 15. Centre de référence des cytopénies auto-immunes de l'adulte, Service de Médecine Interne, CHU Henri Mondor, 51 Avenue du Maréchal de Lattre de Tassigny, 94010 Créteil, France. 16. Département de Médecine Interne, Hôpital Bichat, Université Paris Diderot, AP-HP, 46 Rue Henri Huchard, 75018 Paris, France; INSERM U1149, 16 rue Henri Huchard, 75890 Paris, France; Département Hospitalo-Universitaire FIRE (Fibrosis, Inflammation and REmodelling in Renal and Respiratory Diseases), Université Paris Diderot, PRES Sorbonne Paris Cité, 5 Rue Thomas Mann, 75013, France. 17. Université de Lille, CHU Lille, LIRIC - INSERM U995, FHU Imminent, Hôpital Claude Huriez, Rue Michel Polonovski, 59037 Lille, France. 18. Université de Versailles Saint-Quentin-en-Yvelines (UVSQ), 55 Avenue de Paris, 78000 Versailles, France; Inserm U1016, Institut Cochin, Department of Immunology, 22 Rue Mechain, 75014 Paris, France; UF de dermatologie-immunologie clinique, Hôpital Ambroise Paré, AP-HP, 9 Avenue Charles de Gaulle, 92100 Boulogne-Billancourt, France. 19. Inserm UMR 1153, Équipe de recherche en épidémiologie obstétricale, périnatale et pédiatrique (EPOPé), Centre de recherche épidémiologie et statistique Sorbonne Paris Cité, DHU risques et grossesse, Université Pierre et Marie Curie, 1 place du Parvis Notre-Dame, 75004 Paris, France. 20. LASER Europe Ltd, London, 66 Chiltern St, London W1U 4JT, United Kingdom; Department of Epidemiology, London School of Hygiene and Tropical Medicine, Keppel St, London WC1E 7HT, UK.
Abstract
BACKGROUND: Safety of HPV vaccines is still in question due to reports of autoimmune diseases (ADs) following HPV immunization. OBJECTIVES: To assess the risk of ADs associated with HPV vaccination of female adolescents/young adults in France. METHODS: Systematic prospective case-referent study conducted to assess the risks associated with real-life use of HPV vaccines. Cases were female 11-25 years old with incident ADs [central demyelination/multiple sclerosis (CD/MS), connective tissue disease (CTD), Guillain-Barré syndrome (GBS), type-1 diabetes (T1D), autoimmune thyroiditis (AT), and idiopathic thrombocytopenic purpura (ITP)]. Cases were consecutively and prospectively identified at specialized centers across France (2008-2014) and individually matched by age and place of residence to referents recruited in general practice. Risk was computed using multivariate conditional logistic regression models adjusted for family history of ADs, living in France (north/south), co-medications and co-vaccinations. RESULTS: With a total of 478 definite cases matched to 1869 referents, all ADs combined were negatively associated to HPV vaccination with an adjusted odds ratio of 0.58 (95% confidence interval: 0.41-0.83). Similar results were obtained for CD/MS, AT, CT, and T1D, the last two not reaching statistical significance. No association was found for ITP and GBS. Sensitivity analyses combining definite and possible cases with secondary time window showed similar results. CONCLUSION: Exposure to HPV vaccines was not associated with an increased risk of ADs within the time period studied. Results were robust to case definitions and time windows of exposure. Continued active surveillance is needed to confirm this finding for individual ADs.
BACKGROUND: Safety of HPV vaccines is still in question due to reports of autoimmune diseases (ADs) following HPV immunization. OBJECTIVES: To assess the risk of ADs associated with HPV vaccination of female adolescents/young adults in France. METHODS: Systematic prospective case-referent study conducted to assess the risks associated with real-life use of HPV vaccines. Cases were female 11-25 years old with incident ADs [central demyelination/multiple sclerosis (CD/MS), connective tissue disease (CTD), Guillain-Barré syndrome (GBS), type-1 diabetes (T1D), autoimmune thyroiditis (AT), and idiopathic thrombocytopenic purpura (ITP)]. Cases were consecutively and prospectively identified at specialized centers across France (2008-2014) and individually matched by age and place of residence to referents recruited in general practice. Risk was computed using multivariate conditional logistic regression models adjusted for family history of ADs, living in France (north/south), co-medications and co-vaccinations. RESULTS: With a total of 478 definite cases matched to 1869 referents, all ADs combined were negatively associated to HPV vaccination with an adjusted odds ratio of 0.58 (95% confidence interval: 0.41-0.83). Similar results were obtained for CD/MS, AT, CT, and T1D, the last two not reaching statistical significance. No association was found for ITP and GBS. Sensitivity analyses combining definite and possible cases with secondary time window showed similar results. CONCLUSION: Exposure to HPV vaccines was not associated with an increased risk of ADs within the time period studied. Results were robust to case definitions and time windows of exposure. Continued active surveillance is needed to confirm this finding for individual ADs.
Authors: Abraham Degarege; Karl Krupp; Kristopher Fennie; Tan Li; Dionne P Stephens; Laura A V Marlow; Vijaya Srinivas; Anjali Arun; Purnima Madhivanan Journal: J Pediatr Adolesc Gynecol Date: 2018-03-26 Impact factor: 1.814
Authors: Alexandru Barboi; Christopher H Gibbons; Felicia Axelrod; Eduardo E Benarroch; Italo Biaggioni; Mark W Chapleau; Gisela Chelimsky; Thomas Chelimsky; William P Cheshire; Victoria E Claydon; Roy Freeman; David S Goldstein; Michael J Joyner; Horacio Kaufmann; Phillip A Low; Lucy Norcliffe-Kaufmann; David Robertson; Cyndya A Shibao; Wolfgang Singer; Howard Snapper; Steven Vernino; Satish R Raj Journal: Clin Auton Res Date: 2019-09-02 Impact factor: 4.435
Authors: Verónica Calonga-Solís; Leonardo M Amorim; Ticiana D J Farias; Maria Luiza Petzl-Erler; Danielle Malheiros; Danillo G Augusto Journal: Immunology Date: 2020-10-09 Impact factor: 7.397
Authors: S M Garland; J M L Brotherton; A B Moscicki; A M Kaufmann; M Stanley; N Bhatla; R Sankaranarayanan; S de Sanjosé; J M Palefsky Journal: Papillomavirus Res Date: 2017-06-03
Authors: W Katherine Yih; Judith C Maro; Michael Nguyen; Meghan A Baker; Carolyn Balsbaugh; David V Cole; Inna Dashevsky; Adamma Mba-Jonas; Martin Kulldorff Journal: Am J Epidemiol Date: 2018-06-01 Impact factor: 4.897